Long COVID pathophysiology

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 11:43, August 13, 2021 by Notjusttired (talk | contribs) (add summary quote)

A number of research studies have investigated long COVID or Post-Acute Sequelae of COVID-19 (PASC), the long term health problems that occur in a significant minority of people who remained ill for an extended time after developing COVID-19.


Research has found ongoing endothelial dysfunction, hypometabolism in the brains of long Covid patients, microclots in long Covid blood samples, reduced aerobic capacity and impaired systemic oxygen extraction in non-hospitalized patients without cardiopulmonary disease, disrupted gut microbiota that persists over time, damage to corneal nerves, immunologic dysfunction persisting for at least eight months, numerous findings of dysautonomia (a common post-viral disorder of the autonomic nervous system), and countless other conditions.[1]

—Hannah Davis,  The Guardian


Overview[edit | edit source]

Pathophysiology[edit | edit source]

Infection and immunity[edit | edit source]

A range of antibodies have been found in patients with persistent post-acute COVID symptoms. Elevated G-protein coupled receptor autoantibodies have been found.[2] One study founded elevated antinuclear antibody (ANA) titles in 43.6% of long COVID patients twelve months after symptom onset.[3]

Long COVID may be associated herpesvirus reactivation such as Epstein-Barr Virus,[4] which has been shown to cause elevations of certain G-protein coupled receptor autoantibody types.[5][6][7][8]

Neurological and neuropsychiatric[edit | edit source]

Cardiovascular[edit | edit source]

Pulmonary[edit | edit source]

In a single cardiopulmonary exercise test, Post-COVID-19 patients exhibited markedly reduced peak exercise aerobic capacity (VO2) compared to controls and impaired oxygen extraction, even in those without cardiopulmonary disease.[9]

Comparison to other conditions[edit | edit source]

Findings Long COVID Post-acute SARS ME/CFS POTS MCAS
G-protein coupled receptor autoantibodies β2- and α1-adrenoceptors, angiotensin II AT1-, muscarinic M2-, MAS-, nociceptin- and ETA-receptors M3 and M4 muscarinic acetylcholine receptors, as well as ß2 adrenergic receptors α1, β1 and β2 adrenergic receptor autoantibodies

Post-SARS syndrome[edit | edit source]

ME/CFS[edit | edit source]

Postviral fatigue syndrome[edit | edit source]

Chronic fatigue and Idiopathic chronic fatigue[edit | edit source]

POTS[edit | edit source]

MCAS[edit | edit source]

Post-Ebola syndrome[edit | edit source]

Chronic Epstein-Barr virus[edit | edit source]

Alzheimer's disease[edit | edit source]

Traumatic Brain Injury[edit | edit source]

Notable studies[edit | edit source]

  • 2021, 18F-FDG brain PET hypometabolism in patients with long COVID[10] (Full text)
  • 2021, Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients[11] (Full text)
  • 2021, Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID[12] (Full text)
  • 2021, Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19[13] (Full text) - Pre-print
  • 2021, Persistent clotting protein pathology in Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin[14] (Full text) - Pre-print
  • 2021, Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection[15] (Full text) - Pre-print
  • 2021, Clinical characterization of dysautonomia in long COVID-19 patients[16] (Full text)
  • 2021, Persistent Exertional Intolerance after COVID-19: Insights from Invasive Cardiopulmonary Exercise Testing[17] (Full text)
  • 2021, Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome[18] (Full text)
  • 2021, Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms[19] (Full text)
  • 2020, Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria[20] (Full text)
  • 2020, Multi-organ impairment in low-risk individuals with long COVID[21] (Full text) - Pre-print
  • 2020, Living with covid-19. A dynamic review of the evidence around ongoing covid-19 symptoms (often called long covid)[22] (Full text)

News and articles[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. Davis, Hannah (August 12, 2021). "When it comes to breakthrough cases, are we ignoring long Covid once again?". The Guardian.
  2. "Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms". Journal of Translational Autoimmunity. 4: 100100. January 1, 2021. doi:10.1016/j.jtauto.2021.100100. ISSN 2589-9090.
  3. Seeßle, Jessica; Waterboer, Tim; Hippchen, Theresa; Simon, Julia; Kirchner, Marietta; Lim, Adeline; Müller, Barbara; Merle, Uta (July 5, 2021). "Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study". Clinical Infectious Diseases (ciab611). doi:10.1093/cid/ciab611. ISSN 1058-4838.
  4. Gold, Jeffrey E.; Okyay, Ramazan A.; Licht, Warren E.; Hurley, David J. (June 2021). "Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation". Pathogens. 10 (6): 763. doi:10.3390/pathogens10060763.
  5. Giannoni, Francesca; Albani, Salvatore (2002). "Molecular mimicry and autoimmunity". In Angelini, Lucia; Bardare, Maria; Martini, Alberto; Pierfranco, Fondazione; Mariani, Luisa (eds.). Immune-mediated Disorders of the Central Nervous System in Children. Mariani Foundation paediatric neurology. 10. John Libbey Eurotext. p. 7. ISBN 0861966317.
  6. Gebhardt, B. M. (June 26, 2000). "Evidence for antigenic cross-reactivity between herpesvirus and the acetylcholine receptor". Journal of Neuroimmunology. 105 (2): 145–153. ISSN 0165-5728. PMID 10742556.
  7. Brenner, T.; Timore, Y.; Wirguin, I.; Abramsky, O.; Steinitz, M. (October 1989). "In vitro synthesis of antibodies to acetylcholine receptor by Epstein-Barr virus-stimulated B-lymphocytes derived from patients with myasthenia gravis". Journal of Neuroimmunology. 24 (3): 217–222. ISSN 0165-5728. PMID 2553772.
  8. Kaminski, Henry J.; Janos, Minarovits. "Epstein-barr virus: Trigger for autoimmunity?". Annals of Neurology. ISSN 0364-5134.
  9. Singh, Inderjit; Joseph, Phillip; Heerdt, Paul M.; Cullinan, Marjorie; Lutchmansingh, Denyse D.; Gulati, Mridu; Possick, Jennifer D.; Systrom, David M.; Waxman, Aaron B. (August 10, 2021). "Persistent Exertional Intolerance after COVID-19: Insights from Invasive Cardiopulmonary Exercise Testing". CHEST. 0 (0). doi:10.1016/j.chest.2021.08.010. ISSN 0012-3692.
  10. Guedj, E.; Campion, J. Y.; Dudouet, P.; Kaphan, E.; Bregeon, F.; Tissot-Dupont, H.; Guis, S.; Barthelemy, F.; Habert, P. (August 1, 2021). "18F-FDG brain PET hypometabolism in patients with long COVID". European Journal of Nuclear Medicine and Molecular Imaging. 48 (9): 2823–2833. doi:10.1007/s00259-021-05215-4. ISSN 1619-7089. PMC 7837643. PMID 33501506.
  11. Blitshteyn, Svetlana; Whitelaw, Sera (April 1, 2021). "Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients". Immunologic Research. 69 (2): 205–211. doi:10.1007/s12026-021-09185-5. ISSN 1559-0755. PMC 8009458. PMID 33786700.
  12. Bitirgen, Gulfidan; Korkmaz, Celalettin; Zamani, Adil; Ozkagnici, Ahmet; Zengin, Nazmi; Ponirakis, Georgios; Malik, Rayaz A. (July 8, 2021). "Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID". British Journal of Ophthalmology. doi:10.1136/bjophthalmol-2021-319450. ISSN 0007-1161. PMID 34312122.
  13. https://gut.bmj.com/content/70/4/698
  14. Pretorius, Etheresia; Vlok, Mare; Venter, Chantelle; Bezuidenhout, Johannes A.; Laubscher, Gert Jacobus; Steenkamp, Janami; Kell, Douglas B. (May 24, 2021). "Persistent clotting protein pathology in Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin". medRxiv: 2021.05.21.21257578. doi:10.1101/2021.05.21.21257578.
  15. Phetsouphanh, Chansavath; Darley, David; Howe, Anette; Munier, C. Mee Ling; Patel, Sheila K.; Juno, Jenifer A.; Burrell, Louise M.; Kent, Stephen J.; Dore, Gregory J. (June 3, 2021). "Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection". medRxiv: 2021.06.01.21257759. doi:10.1101/2021.06.01.21257759.
  16. Barizien, Nicolas; Le Guen, Morgan; Russel, Stéphanie; Touche, Pauline; Huang, Florent; Vallée, Alexandre (July 7, 2021). "Clinical characterization of dysautonomia in long COVID-19 patients". Scientific Reports. 11 (1): 14042. doi:10.1038/s41598-021-93546-5. ISSN 2045-2322.
  17. Singh, Inderjit; Joseph, Phillip; Heerdt, Paul M.; Cullinan, Marjorie; Lutchmansingh, Denyse D.; Gulati, Mridu; Possick, Jennifer D.; Systrom, David M.; Waxman, Aaron B. (August 10, 2021). "Persistent Exertional Intolerance after COVID-19: Insights from Invasive Cardiopulmonary Exercise Testing". CHEST. doi:10.1016/j.chest.2021.08.010. ISSN 0012-3692.
  18. https://onlinelibrary.wiley.com/doi/epdf/10.1111/jth.15490
  19. Proal, Amy D.; VanElzakker, Michael B. (2021). "Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms". Frontiers in Microbiology. doi:10.3389/fmicb.2021.698169. ISSN 1664-302X. PMC 8260991. PMID 34248921.
  20. Raveendran, A.V. (2021). "Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria". Diabetes & Metabolic Syndrome. 15 (1): 145–146. doi:10.1016/j.dsx.2020.12.025. ISSN 1871-4021. PMC 7737559. PMID 33341598.
  21. Dennis, Andrea; Wamil, Malgorzata; Kapur, Sandeep; Alberts, Johann; Badley, Andrew D.; Decker, Gustav Anton; Rizza, Stacey A.; Banerjee, Rajarshi; Banerjee, Amitava (October 16, 2020). "Multi-organ impairment in low-risk individuals with long COVID". medRxiv: 2020.10.14.20212555. doi:10.1101/2020.10.14.20212555.
  22. National Institute for Health Research (October 2020). "Living with covid-19. A dynamic review of the evidence around ongoing covid-19 symptoms (often called long covid)". National Institute for Health Research. doi:10.3310/themedreview_41169. Retrieved October 15, 2020.